2020 ESC Guidelines on acute coronary syndrome without ST-segment elevation: recommendations and critical appraisal from the Dutch ACS and Interventional Cardiology working groups

Autor: T.J.F. ten Cate, Yolande Appelman, D. J. van der Heijden, A. de Vos, A. W. J. van ’t Hof, S. Assa, Joop Jukema, P. Woudstra, M. L. J. van der Wielen, P. Damman, Reinier A. Waalewijn, Pieter-Jan Vlaar, Michiel Voskuil, W. Balder, Bastiaan Zwart, J. M. ten Berg, R. S. Hermanides, N. van Royen, Maarten A. Vink, F. Arslan, Jorrit S. Lemkes

Publikováno v: Netherlands Heart Journal, 29(11), 557-565. BOHN STAFLEU VAN LOGHUM BV
Netherlands Heart Journal, 29(11), 557-565. Bohn Stafleu van Loghum
Netherlands Heart Journal, 29, 11, pp. 557-565
Netherlands Heart Journal, 29, 557-565
Arslan, F, Damman, P, Zwart, B, Appelman, Y, Voskuil, M, de Vos, A, van Royen, N, Jukema, J W, Waalewijn, R, Hermanides, R S, Woudstra, P, ten Cate, T, Lemkes, J S, Vink, M A, Balder, W, van der Wielen, M L J, Vlaar, P J, van der Heijden, D J, Assa, S, van ’t Hof, A W & ten Berg, J M 2021, ' 2020 ESC Guidelines on acute coronary syndrome without ST-segment elevation : Recommendations and critical appraisal from the Dutch ACS and Interventional Cardiology working groups ', Netherlands Heart Journal, vol. 29, no. 11, pp. 557-565 . https://doi.org/10.1007/s12471-021-01593-4
Netherlands Heart Journal, 29(11), 557-565. Bohn, Stafleu, Van Loghum

Contains fulltext : 245649.pdf (Publisher’s version ) (Open Access) Recently, the European Society of Cardiology (ESC) has updated its guidelines for the management of patients with acute coronary syndrome (ACS) without ST-segment elevation. The cu

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00577884155eadd23224b917d0b8d9c6
https://link.springer.com/content/pdf/10.1007/s12471-021-01593-4.pdf

Safety of Selective Intracoronary Hypothermia During Primary Percutaneous Coronary Intervention in Patients With Anterior STEMI

Autor: Thomas Engstrøm, Thomas R. Keeble, Pieter-Jan Palmers, Bernard De Bruyne, Guus R. G. Brueren, Richard Good, Inge Wijnbergen, R.J. Snijder, Jacob Lønborg, Kenneth Mangion, Keith G. Oldroyd, Mohamed El Farissi, Colin Berry, Pieter J. Vlaar, Nico H.J. Pijls, Bastiaan Zwart, Koen Teeuwen, Luuk C. Otterspoor, Annemiek De Vos, Ole Fröbert, Pim A.L. Tonino, Grigoris V. Karamasis

Publikováno v: El Farissi, M, Good, R, Engstrøm, T, Oldroyd, K G, Karamasis, G V, Vlaar, P J, Lønborg, J T, Teeuwen, K, Keeble, T R, Mangion, K, De Bruyne, B, Fröbert, O, De Vos, A, Zwart, B, Snijder, R J R, Brueren, G R G, Palmers, P J, Wijnbergen, I F, Berry, C, Tonino, P A L, Otterspoor, L C & Pijls, N H J 2021, ' Safety of Selective Intracoronary Hypothermia During Primary Percutaneous Coronary Intervention in Patients With Anterior STEMI ', JACC: Cardiovascular Interventions, vol. 14, no. 18, pp. 2047-2055 . https://doi.org/10.1016/j.jcin.2021.06.009

Objectives The aim of this study was to determine the safety of selective intracoronary hypothermia during primary percutaneous coronary intervention (PPCI) in patients with anterior ST-segment elevation myocardial infarction (STEMI). Background Sele

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e5fdf7908429789577d2160902028988
https://pubmed.ncbi.nlm.nih.gov/34454853

Identifying high thrombotic risk in atrial fibrillation patients undergoing percutaneous coronary intervention: is there a benefit of triple therapy?

Autor: W L Bor, A. J. W. M. de Veer, J. M. ten Berg, Bastiaan Zwart, Johannes C. Kelder, Christopher P. Cannon, Bakhtawar K. Mahmoodi

Publikováno v: European Heart Journal. 41

Introduction Patients requiring concomittant use of oral anticoagulants for atrial fibrillation and dual antiplatelet therapy after percutaneous coronary intervention (PCI) are at increased risk of bleeding and mortality. Omittance of aspirin (dual a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::5b5da9d647352be4fc162a3cfed922f5
https://doi.org/10.1093/ehjci/ehaa946.1451

Atrial fibrillation and coronary stenting: is the AUGUSTUS trial the end of triple therapy?

Autor: Bastiaan Zwart, Jurriën M. ten Berg

Publikováno v: Future Cardiology. 15:319-321

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d11a4daf73a237170898ca74b680c42e
https://doi.org/10.2217/fca-2019-0027

Measuring high on-treatment platelet reactivity in clinical practice; should we use a panel of platelet function tests?

Autor: Kai Zheng, Jurriën M. ten Berg, Johannes C. Kelder, Thea C. Godschalk, Bastiaan Zwart, Job Denteneer

Publikováno v: Blood coagulationfibrinolysis : an international journal in haemostasis and thrombosis. 30(6)

High on-treatment platelet reactivity (HPR) on P2Y12-inhibitors in patients treated with dual antiplatelet therapy is strongly associated with adverse ischaemic events. Studies have shown conflicting results with regard to the correlation and agreeme

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d65f9d7dbde9f046c228c88f8b8ad44
https://pubmed.ncbi.nlm.nih.gov/31259779